Low Molecular Weight Heparin Therapy: An Evaluation of Clinical Trials Evidence

By Monique Sarret, André Kher, Francis Toulemonde

Each section is followed with expert commentary and a critical evaluation of the studies under consideration This reference, unique in format, gathers the most relevant clinical studies, reviews the different biochemical properties, and assesses the therapeutic efficacy of low molecular weight heparins (LMWHs) from 1985 to the present. Presents each study on two pages-the first describes the main parameters of the study, including experimental conditions, location, number of patients, medications, surgical procedures, and anesthesia type, and the second provides a table of results based on the study's data With contributions from 35 leading international physicians, Low Molecular Weight Heparin Therapy recommends treatment practices based on levels of evidence attained in the studies questions specific therapeutic practices when researchers fail to provides systematic documentation of the various therapeutic indications of LMWHs compares the benefits of LMWHs prophylaxis with the risk of hemorrhage evaluates the ease of delivery of prophylactic therapy and treatment of thromboembolic disease favors narrative review of each study over meta-analysis and more Containing hundreds of tables, and scrupulously referenced to substantiate the critical appraisals, Low Molecular Weight Heparin Therapy is a single-volume reference ideal for anesthesiologists, surgeons, primary care physicians, internists, cardiologists, hematologists, pharmacologists, epidemiologists, and medical students in these disciplines.

• Format: Hardcover
• Language: English
• ISBN: 0824782135
• ISBN13: 9780824782139
• Release Date: September 1999
• Publisher: CRC Press
• Length: 488 Pages
• Weight: 0.47 lbs.
• Dimensions: 9.5" x 1.3" x 8.5"